Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.
A pair of researchers in the Department of Neurobiology and Behavior are designing new technology and research methods to discover how brain circuits support learning and memory.
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.
For talkative midshipman fish, the midbrain plays a key role in patterning trains of sounds and may serve as a model for how mammals, including humans, control vocal expression.
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide.
Over 10 weeks, 22 teams of would-be entrepreneurs developed products ranging from multilingual children's toys to innovative greenhouse hoops for small-scale farmers.
An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.
A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.
Collaboration was the theme of the evening at the second annual Community Engagement Awards, held April 16 and hosted by the Einhorn Center for Community Engagement to celebrate excellence in local and global university-community partnerships.